NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
Lifespan Edge FAQ: New Longevity Clinics in Florida and Maryland
Lifespan Edge, a next-generation longevity clinic co-founded by John Mauldin and Dr. Michael Roizen, has opened new locations in West Palm Beach, FL, and Columbia, MD, with a third coming to Scottsdale, AZ. The clinics offer personalized, evidence-based care focused on prevention, cognitive vitality, and healthy aging.
Lifespan Edge is a next-generation longevity clinic co-founded by futurist John Mauldin and preventive medicine pioneer Dr. Michael Roizen. It bridges cutting-edge longevity research with individualized clinical care to optimize healthspan, cognitive vitality, and quality of life.
New clinics are open in West Palm Beach, Florida (2528 Okeechobee Blvd., West Palm Beach, FL 33409) and Columbia, Maryland (10700 Charter Drive, Suite 200, Columbia, MD 21044). A third location is planned for Scottsdale, Arizona.
Each location provides a concierge-style experience combining advanced diagnostics, physician-guided evaluations, and personalized strategies focused on prevention, performance, and healthy aging.
Lifespan Edge was co-founded by futurist John Mauldin (President and Co-Founder) and preventive medicine pioneer Dr. Michael Roizen (Chair of the Board and Co-Founder).
Lifespan Edge believes healthcare should begin decades before disease appears. They emphasize that many aging factors are modifiable through personalized care, informed lifestyle choices, and emerging scientific advances.
Lifespan Edge highlights research in Therapeutic Plasma Exchange (TPE) and the AMBAR (Alzheimer Management by Albumin Replacement) clinical trial, which evaluated plasma exchange with albumin replacement in patients with mild-to-moderate Alzheimer’s.
Lifespan Edge was founded in 2024, though the article does not specify the exact opening date of the first clinic.
You can visit their website at lifespan-edge.com or their locations page at https://lifespan-edge.com/locations/ for more information.